ingredient,nbk_id,title,url
- caffeine -saw palmetto -rosemary - aloe vera - biotin -vitamin c -keratin -jojoba -lavender -olive oil - almond oil - thyme - panthenol -a powerful management for telegen effluvium & androgenetic alopecia -powerfully stimulates scalp circulation and stimulates hair growth -elongating the anagen phase in hair follicles -stimulates production in hair. *indicated in: -hair falling -weak and damaged hair -hair shaft abnormalities (split ends) -dry hair and treated with chmical (dyes) -post hair transplantation *suitable for dry and oily scalp,NBK551714,Table,https://www.ncbi.nlm.nih.gov/books/NBK551714/
..,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
...,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
1,NBK560567,Table 1. 2016 World Health Organization Classification,https://www.ncbi.nlm.nih.gov/books/NBK560567/
10%urea,NBK599513,Nitrosoureas Toxicity,https://www.ncbi.nlm.nih.gov/books/NBK599513/
100mg calcium,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
12,NBK585133,Table 12. Differential Diagnosis of Charles Bonnet Syndrome,https://www.ncbi.nlm.nih.gov/books/NBK585133/
13.06 mg),NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
15 ml,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
170mg epa,NBK587440,Preparation,https://www.ncbi.nlm.nih.gov/books/NBK587440/
1ml,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
2,NBK560567,Table 2. Endoscopic Third Ventriculostomy Success Score,https://www.ncbi.nlm.nih.gov/books/NBK560567/
2.5 mg iron,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
20 mg vitamin a),NBK546667,Table 9. Minimum Daily Vitamin and Mineral Intake After Bariatric Surgery,https://www.ncbi.nlm.nih.gov/books/NBK546667/
23 mg,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
27 mg iron,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
3,NBK560880,Table 3. Differential Diagnosis by Severity,https://www.ncbi.nlm.nih.gov/books/NBK560880/
3%,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
370 mg sodium,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
5 ml,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
50 mg,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
5ml,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
6,NBK560567,Table 1. 2016 World Health Organization Classification,https://www.ncbi.nlm.nih.gov/books/NBK560567/
a,NBK560668,Enhancing Healthcare Team Outcomes,https://www.ncbi.nlm.nih.gov/books/NBK560668/
a),NBK560668,Enhancing Healthcare Team Outcomes,https://www.ncbi.nlm.nih.gov/books/NBK560668/
adenosine,NBK544321,Table. Dipyridamole Effects on Adenosine Receptors,https://www.ncbi.nlm.nih.gov/books/NBK544321/
aha,NBK606116,ACC/AHA Guidelines for Valve Disease,https://www.ncbi.nlm.nih.gov/books/NBK606116/
aha 3%,NBK606116,ACC/AHA Guidelines for Valve Disease,https://www.ncbi.nlm.nih.gov/books/NBK606116/
al,NBK560668,Enhancing Healthcare Team Outcomes,https://www.ncbi.nlm.nih.gov/books/NBK560668/
ala,NBK546667,Table 2. Malabsorptive Procedures Detailed Comparison,https://www.ncbi.nlm.nih.gov/books/NBK546667/
alcohol,NBK594273,The Emerging Role of Bariatric Surgery in the Management of Nonalcoholic Fatty Liver Disease,https://www.ncbi.nlm.nih.gov/books/NBK594273/
alcohol 70%,NBK594273,The Emerging Role of Bariatric Surgery in the Management of Nonalcoholic Fatty Liver Disease,https://www.ncbi.nlm.nih.gov/books/NBK594273/
alcohol 80%,NBK594273,The Emerging Role of Bariatric Surgery in the Management of Nonalcoholic Fatty Liver Disease,https://www.ncbi.nlm.nih.gov/books/NBK594273/
alcohol 95%,NBK594273,The Emerging Role of Bariatric Surgery in the Management of Nonalcoholic Fatty Liver Disease,https://www.ncbi.nlm.nih.gov/books/NBK594273/
alum,NBK609094,Aluminum Toxicity,https://www.ncbi.nlm.nih.gov/books/NBK609094/
aluminum sulfate,NBK609094,Aluminum Toxicity,https://www.ncbi.nlm.nih.gov/books/NBK609094/
amikacin,NBK549902,Table 2. Toxicity Profile of Amikacin and TMP-SMX,https://www.ncbi.nlm.nih.gov/books/NBK549902/
anis,NBK570558,Table 1. Etiological Categories and Mechanisms of Duane Retraction Syndrome,https://www.ncbi.nlm.nih.gov/books/NBK570558/
asu,NBK470281,Table. HIV Prevention Measures,https://www.ncbi.nlm.nih.gov/books/NBK470281/
atp,NBK557428,Aortic regurgitation sound StatPearls,https://www.ncbi.nlm.nih.gov/books/NBK557428/
b,NBK560567,Table 4. Prognosis Summary of Pineal Region Tumors,https://www.ncbi.nlm.nih.gov/books/NBK560567/
b),NBK560567,Table 4. Prognosis Summary of Pineal Region Tumors,https://www.ncbi.nlm.nih.gov/books/NBK560567/
bacopa monnerei,NBK589635,Bacopa monnieri,https://www.ncbi.nlm.nih.gov/books/NBK589635/
baricitinib,NBK589640,Safe and Effective Use of Baricitinib and Remdesivir in Hospitalized Patients With Coronavirus (COVID-19),https://www.ncbi.nlm.nih.gov/books/NBK589640/
bempedoic acid,NBK594232,Bempedoic Acid,https://www.ncbi.nlm.nih.gov/books/NBK594232/
bet,NBK619810,Table 1. A Comparison Between Holmium Laser Enucleation of the Prostate and Thulium Laser Enucleation of the Prostate,https://www.ncbi.nlm.nih.gov/books/NBK619810/
bran,NBK525949,Table 1. Available Oral Isotretinoin Formulations and Brand Names,https://www.ncbi.nlm.nih.gov/books/NBK525949/
bupropion,NBK618375,Table 5. Naltrexone-Bupropion Clinical Profile,https://www.ncbi.nlm.nih.gov/books/NBK618375/
but,NBK556033,Table 2. Global Infertility Prevalence and Contributing Factors,https://www.ncbi.nlm.nih.gov/books/NBK556033/
c,NBK560668,Enhancing Healthcare Team Outcomes,https://www.ncbi.nlm.nih.gov/books/NBK560668/
c & e,NBK585133,Table 21. Summary of Prognostic Expectations,https://www.ncbi.nlm.nih.gov/books/NBK585133/
c),NBK560668,Enhancing Healthcare Team Outcomes,https://www.ncbi.nlm.nih.gov/books/NBK560668/
ca,NBK560668,Enhancing Healthcare Team Outcomes,https://www.ncbi.nlm.nih.gov/books/NBK560668/
caf,NBK519490,Table. Caffeine Citrate Dosages for Apnea of Prematurity,https://www.ncbi.nlm.nih.gov/books/NBK519490/
caffein,NBK519490,Table. Caffeine Citrate Dosages for Apnea of Prematurity,https://www.ncbi.nlm.nih.gov/books/NBK519490/
caffeine,NBK519490,Table. Caffeine Citrate Dosages for Apnea of Prematurity,https://www.ncbi.nlm.nih.gov/books/NBK519490/
caffeine 2%,NBK519490,Table. Caffeine Citrate Dosages for Apnea of Prematurity,https://www.ncbi.nlm.nih.gov/books/NBK519490/
caffeine 5%,NBK519490,Table. Caffeine Citrate Dosages for Apnea of Prematurity,https://www.ncbi.nlm.nih.gov/books/NBK519490/
caffeine 50 mg,NBK519490,Table. Caffeine Citrate Dosages for Apnea of Prematurity,https://www.ncbi.nlm.nih.gov/books/NBK519490/
calcium,NBK599516,Calcium Deposition and Other Renal Crystal Diseases,https://www.ncbi.nlm.nih.gov/books/NBK599516/
calcium 1000 mg,NBK599516,Calcium Deposition and Other Renal Crystal Diseases,https://www.ncbi.nlm.nih.gov/books/NBK599516/
calcium 1000mg,NBK599516,Calcium Deposition and Other Renal Crystal Diseases,https://www.ncbi.nlm.nih.gov/books/NBK599516/
calcium 150mg,NBK599516,Calcium Deposition and Other Renal Crystal Diseases,https://www.ncbi.nlm.nih.gov/books/NBK599516/
calcium 200mg,NBK599516,Calcium Deposition and Other Renal Crystal Diseases,https://www.ncbi.nlm.nih.gov/books/NBK599516/
calcium 210 mg,NBK599516,Calcium Deposition and Other Renal Crystal Diseases,https://www.ncbi.nlm.nih.gov/books/NBK599516/
calcium 400mg,NBK599516,Calcium Deposition and Other Renal Crystal Diseases,https://www.ncbi.nlm.nih.gov/books/NBK599516/
calcium 800mg,NBK599516,Calcium Deposition and Other Renal Crystal Diseases,https://www.ncbi.nlm.nih.gov/books/NBK599516/
calcium acetate,NBK599516,Calcium Deposition and Other Renal Crystal Diseases,https://www.ncbi.nlm.nih.gov/books/NBK599516/
calcium*,NBK599516,Calcium Deposition and Other Renal Crystal Diseases,https://www.ncbi.nlm.nih.gov/books/NBK599516/
canagliflozin,NBK603733,Canagliflozin,https://www.ncbi.nlm.nih.gov/books/NBK603733/
carbidopa,NBK599508,Levodopa/Carbidopa/Entacapone Combination Therapy,https://www.ncbi.nlm.nih.gov/books/NBK599508/
carboplatin,NBK617056,"Table 1. Frequency and Key Risk Factors of Platinum Hypersensitivity Reactions Associated with Cisplatin, Carboplatin, and Oxaliplatin",https://www.ncbi.nlm.nih.gov/books/NBK617056/
cefotaxime,NBK599503,Cefuroxime,https://www.ncbi.nlm.nih.gov/books/NBK599503/
cefuroxime,NBK599503,Cefuroxime,https://www.ncbi.nlm.nih.gov/books/NBK599503/
chromium,NBK599502,Chromium Toxicity,https://www.ncbi.nlm.nih.gov/books/NBK599502/
chromium 0.498 mg,NBK599502,Chromium Toxicity,https://www.ncbi.nlm.nih.gov/books/NBK599502/
chromium 100 iu,NBK599502,Chromium Toxicity,https://www.ncbi.nlm.nih.gov/books/NBK599502/
chromium 50 mcg,NBK599502,Chromium Toxicity,https://www.ncbi.nlm.nih.gov/books/NBK599502/
chromium 804.4 mcg,NBK599502,Chromium Toxicity,https://www.ncbi.nlm.nih.gov/books/NBK599502/
cisplatin,NBK617056,"Table 1. Frequency and Key Risk Factors of Platinum Hypersensitivity Reactions Associated with Cisplatin, Carboplatin, and Oxaliplatin",https://www.ncbi.nlm.nih.gov/books/NBK617056/
citrate,NBK519490,Table. Caffeine Citrate Dosages for Apnea of Prematurity,https://www.ncbi.nlm.nih.gov/books/NBK519490/
cl,NBK560567,Table 1. 2016 World Health Organization Classification,https://www.ncbi.nlm.nih.gov/books/NBK560567/
cla,NBK560567,Table 1. 2016 World Health Organization Classification,https://www.ncbi.nlm.nih.gov/books/NBK560567/
cr,NBK556105,Table 2. Diagnostic Criteria for CAA–Related Inflammation (CAA-RI),https://www.ncbi.nlm.nih.gov/books/NBK556105/
cu,NBK560567,Table 2. Endoscopic Third Ventriculostomy Success Score,https://www.ncbi.nlm.nih.gov/books/NBK560567/
cyclosporin,NBK592419,Voclosporin,https://www.ncbi.nlm.nih.gov/books/NBK592419/
d,NBK482370,Pearls and Other Issues,https://www.ncbi.nlm.nih.gov/books/NBK482370/
d),NBK482370,Pearls and Other Issues,https://www.ncbi.nlm.nih.gov/books/NBK482370/
dalteparin sodium,NBK603711,Dalteparin,https://www.ncbi.nlm.nih.gov/books/NBK603711/
dapagliflozin,NBK603733,Canagliflozin,https://www.ncbi.nlm.nih.gov/books/NBK603733/
de,NBK560668,Deterrence and Patient Education,https://www.ncbi.nlm.nih.gov/books/NBK560668/
dextromethorphan,NBK604212,Dextromethorphan Guaifenesin,https://www.ncbi.nlm.nih.gov/books/NBK604212/
dill,NBK500015,Table 2. Cardillo Tracheal Injury Classification,https://www.ncbi.nlm.nih.gov/books/NBK500015/
dipyridamole,NBK544321,Table. Dipyridamole Effects on Adenosine Receptors,https://www.ncbi.nlm.nih.gov/books/NBK544321/
dulaglutide,NBK608007,Liraglutide,https://www.ncbi.nlm.nih.gov/books/NBK608007/
dutasteride,NBK603726,Dutasteride,https://www.ncbi.nlm.nih.gov/books/NBK603726/
e,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
e k),NBK549887,Table 5. Long-Term Visual Outcomes After Photorefractive Keratectomy,https://www.ncbi.nlm.nih.gov/books/NBK549887/
e),NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
eba,NBK610689,Sebaceous Carcinoma,https://www.ncbi.nlm.nih.gov/books/NBK610689/
eletriptan,NBK599497,Eletriptan,https://www.ncbi.nlm.nih.gov/books/NBK599497/
entacapone,NBK599508,Levodopa/Carbidopa/Entacapone Combination Therapy,https://www.ncbi.nlm.nih.gov/books/NBK599508/
epa,NBK587440,Preparation,https://www.ncbi.nlm.nih.gov/books/NBK587440/
epa 429 mg,NBK587440,Preparation,https://www.ncbi.nlm.nih.gov/books/NBK587440/
epa 5%),NBK587440,Preparation,https://www.ncbi.nlm.nih.gov/books/NBK587440/
epa),NBK587440,Preparation,https://www.ncbi.nlm.nih.gov/books/NBK587440/
erica,NBK525980,Table. Blood Pressure Classification for Adults According to the 2017 American College of Cardiology and American Heart Association Guidelines,https://www.ncbi.nlm.nih.gov/books/NBK525980/
eru,NBK538255,Table 2. Histopathological Characteristics of Bacterial Infection-Related Glomerulonephritis,https://www.ncbi.nlm.nih.gov/books/NBK538255/
ethyl acetate,NBK594255,Trimethylaminuria,https://www.ncbi.nlm.nih.gov/books/NBK594255/
extract,NBK592391,"Oral Surgery, Extraction of Unerupted Teeth",https://www.ncbi.nlm.nih.gov/books/NBK592391/
f,NBK587440,"Nursing, Allied Health, and Interprofessional Team Monitoring",https://www.ncbi.nlm.nih.gov/books/NBK587440/
f),NBK587440,"Nursing, Allied Health, and Interprofessional Team Monitoring",https://www.ncbi.nlm.nih.gov/books/NBK587440/
fat,NBK430833,Table 2. Nonfatal Drowning Categorization Framework,https://www.ncbi.nlm.nih.gov/books/NBK430833/
fe,NBK587440,"Nursing, Allied Health, and Interprofessional Team Monitoring",https://www.ncbi.nlm.nih.gov/books/NBK587440/
fingolimod,NBK604198,Fingolimod,https://www.ncbi.nlm.nih.gov/books/NBK604198/
flibanserin,NBK589649,Flibanserin,https://www.ncbi.nlm.nih.gov/books/NBK589649/
fluvoxamine maleate,NBK619811,Fluvoxamine,https://www.ncbi.nlm.nih.gov/books/NBK619811/
g,NBK560668,Enhancing Healthcare Team Outcomes,https://www.ncbi.nlm.nih.gov/books/NBK560668/
gemifloxacin,NBK599511,Moxifloxacin,https://www.ncbi.nlm.nih.gov/books/NBK599511/
gl,NBK556033,Table 2. Global Infertility Prevalence and Contributing Factors,https://www.ncbi.nlm.nih.gov/books/NBK556033/
gla,NBK513298,Table. Modified Pediatric Glasgow Coma Scale ,https://www.ncbi.nlm.nih.gov/books/NBK513298/
glucose,NBK549816,Table. Relationship Between HbA1c and Average Glucose Levels,https://www.ncbi.nlm.nih.gov/books/NBK549816/
glucose 40%,NBK549816,Table. Relationship Between HbA1c and Average Glucose Levels,https://www.ncbi.nlm.nih.gov/books/NBK549816/
glyce,NBK546667,Table 12. Causes of Hypoglycemia After RYGB,https://www.ncbi.nlm.nih.gov/books/NBK546667/
glycol,NBK541119,Table 1. Effect of Different Hormones on Key Glycolytic and Gluconeogenic Enzymes,https://www.ncbi.nlm.nih.gov/books/NBK541119/
gm,NBK614165,Anterior Segment Optical Coherence Tomography,https://www.ncbi.nlm.nih.gov/books/NBK614165/
gm),NBK614165,Anterior Segment Optical Coherence Tomography,https://www.ncbi.nlm.nih.gov/books/NBK614165/
gre,NBK618378,Table 9. Progressive Resistance Training Protocol,https://www.ncbi.nlm.nih.gov/books/NBK618378/
guaifenesin,NBK604212,Dextromethorphan Guaifenesin,https://www.ncbi.nlm.nih.gov/books/NBK604212/
ha,NBK560668,Enhancing Healthcare Team Outcomes,https://www.ncbi.nlm.nih.gov/books/NBK560668/
heparin,NBK441880,Table 2. Heparin Regimen Options,https://www.ncbi.nlm.nih.gov/books/NBK441880/
heparin calcium,NBK441880,Table 2. Heparin Regimen Options,https://www.ncbi.nlm.nih.gov/books/NBK441880/
heparin sodium,NBK441880,Table 2. Heparin Regimen Options,https://www.ncbi.nlm.nih.gov/books/NBK441880/
hepatitis b,NBK565864,Table 2. Post-Exposure Treatment of Healthcare Personnel Based on Hepatitis B Vaccination and Serologic Status,https://www.ncbi.nlm.nih.gov/books/NBK565864/
iga,NBK557533,Table. The 2020 Guidelines for Stillbirth Investigation,https://www.ncbi.nlm.nih.gov/books/NBK557533/
igm,NBK599559,Prurigo Pigmentosa,https://www.ncbi.nlm.nih.gov/books/NBK599559/
iron,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
iron 11mg,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
iron 14 mg,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
iron 17mg,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
iron 20 mg,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
iron 28 mg,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
iron 30 mg,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
iron 45 mg,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
iron 7mg,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
iron 8mg,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
iron...,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
iron35mg,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
isotretinoin,NBK525949,Table 1. Available Oral Isotretinoin Formulations and Brand Names,https://www.ncbi.nlm.nih.gov/books/NBK525949/
k,NBK589709,Table. The 2HELPS2B Calculation and Risk Stratification,https://www.ncbi.nlm.nih.gov/books/NBK589709/
k),NBK589709,Table. The 2HELPS2B Calculation and Risk Stratification,https://www.ncbi.nlm.nih.gov/books/NBK589709/
kale),NBK482465,Table 2. Hypokalemia Differential Diagnosis Based on Blood pH,https://www.ncbi.nlm.nih.gov/books/NBK482465/
l,NBK560668,Enhancing Healthcare Team Outcomes,https://www.ncbi.nlm.nih.gov/books/NBK560668/
lactose,NBK532285,Table 1. Key Points to Remember About Lactose Intolerance,https://www.ncbi.nlm.nih.gov/books/NBK532285/
le,NBK560567,Table 4. Prognosis Summary of Pineal Region Tumors,https://www.ncbi.nlm.nih.gov/books/NBK560567/
lecithin,NBK603731,Lecithin-Cholesterol Acyltransferase Deficiency,https://www.ncbi.nlm.nih.gov/books/NBK603731/
levodopa,NBK599508,Levodopa/Carbidopa/Entacapone Combination Therapy,https://www.ncbi.nlm.nih.gov/books/NBK599508/
levothyroxine,NBK538485,Table. Dosing in levothyroxine-naïve hypothyroidism individuals diagnosed during pregnancy ,https://www.ncbi.nlm.nih.gov/books/NBK538485/
liraglutide,NBK608007,Liraglutide,https://www.ncbi.nlm.nih.gov/books/NBK608007/
lysi,NBK459334,Table 2. Standard Reference Ranges for Urine Analysis in Drug Screening,https://www.ncbi.nlm.nih.gov/books/NBK459334/
lysin 80 mg,NBK594238,Table 2. Age-Dependent Upper Normal Limits for Antistreptolysin O and Antideoxyribonuclease B Antibody Titers for Areas of Endemic Group A Streptococcus Disease,https://www.ncbi.nlm.nih.gov/books/NBK594238/
m,NBK560668,Enhancing Healthcare Team Outcomes,https://www.ncbi.nlm.nih.gov/books/NBK560668/
me,NBK560668,Enhancing Healthcare Team Outcomes,https://www.ncbi.nlm.nih.gov/books/NBK560668/
mental,NBK585133,Table 13. Environmental and Behavioural Adjustments for CBS,https://www.ncbi.nlm.nih.gov/books/NBK585133/
met,NBK570558,Table 3. Toxicokinetic Parameters and Their Relevance to Duane Retraction Syndrome,https://www.ncbi.nlm.nih.gov/books/NBK570558/
methy,NBK594255,Trimethylaminuria,https://www.ncbi.nlm.nih.gov/books/NBK594255/
mianserin,NBK589649,Flibanserin,https://www.ncbi.nlm.nih.gov/books/NBK589649/
ml,NBK603716,Table 1. Features of Genetically Defined AML,https://www.ncbi.nlm.nih.gov/books/NBK603716/
mn,NBK562140,"Table. Definitions of Mild, Moderate, and Severe Polyhydramnios",https://www.ncbi.nlm.nih.gov/books/NBK562140/
mo,NBK587440,"Nursing, Allied Health, and Interprofessional Team Monitoring",https://www.ncbi.nlm.nih.gov/books/NBK587440/
moxifloxacin,NBK599511,Moxifloxacin,https://www.ncbi.nlm.nih.gov/books/NBK599511/
ms,NBK570558,Table 1. Etiological Categories and Mechanisms of Duane Retraction Syndrome,https://www.ncbi.nlm.nih.gov/books/NBK570558/
mupirocin,NBK599499,Mupirocin,https://www.ncbi.nlm.nih.gov/books/NBK599499/
naloxone,NBK603725,Buprenorphine and Naloxone,https://www.ncbi.nlm.nih.gov/books/NBK603725/
naltrexone,NBK618375,Table 5. Naltrexone-Bupropion Clinical Profile,https://www.ncbi.nlm.nih.gov/books/NBK618375/
naltrexone hydrochloride,NBK618375,Table 5. Naltrexone-Bupropion Clinical Profile,https://www.ncbi.nlm.nih.gov/books/NBK618375/
nicotinamide,NBK594229,Mohs Micrographic Surgery: Chemoprophylaxis Options for Nicotinamide and Oral Retinoids,https://www.ncbi.nlm.nih.gov/books/NBK594229/
ofloxacin,NBK599511,Moxifloxacin,https://www.ncbi.nlm.nih.gov/books/NBK599511/
olamine,NBK599553,"Table 3. Summary of non-catecholamine therapies for the treatment of vasoplegic syndrome, dosing, mechanism of action, adverse effects, and advantages",https://www.ncbi.nlm.nih.gov/books/NBK599553/
orange,NBK594243,Agent Orange Toxicity,https://www.ncbi.nlm.nih.gov/books/NBK594243/
orlistat,NBK618375,Table 6. Orlistat Clinical Profile,https://www.ncbi.nlm.nih.gov/books/NBK618375/
ors,NBK560567,Table 4. Prognosis Summary of Pineal Region Tumors,https://www.ncbi.nlm.nih.gov/books/NBK560567/
other,NBK482370,Pearls and Other Issues,https://www.ncbi.nlm.nih.gov/books/NBK482370/
oxaliplatin,NBK617056,"Table 1. Frequency and Key Risk Factors of Platinum Hypersensitivity Reactions Associated with Cisplatin, Carboplatin, and Oxaliplatin",https://www.ncbi.nlm.nih.gov/books/NBK617056/
p,NBK482370,Pearls and Other Issues,https://www.ncbi.nlm.nih.gov/books/NBK482370/
p.o.,NBK553107,Table. Flap Options for Common Anatomic Sites of Pressure Injuries [18],https://www.ncbi.nlm.nih.gov/books/NBK553107/
palatable taste,NBK551714,Table,https://www.ncbi.nlm.nih.gov/books/NBK551714/
pan,NBK551613,Table 3. Pancreatic NET Staging,https://www.ncbi.nlm.nih.gov/books/NBK551613/
pea,NBK482370,Pearls and Other Issues,https://www.ncbi.nlm.nih.gov/books/NBK482370/
pemetrexed,NBK606090,Pemetrexed,https://www.ncbi.nlm.nih.gov/books/NBK606090/
photo-stable,NBK551714,Table,https://www.ncbi.nlm.nih.gov/books/NBK551714/
photostable uva and uvb filters,NBK551714,Table,https://www.ncbi.nlm.nih.gov/books/NBK551714/
polidocanol,NBK599526,Table 2. Size requirements for STS and Polidocanol based on concentration.,https://www.ncbi.nlm.nih.gov/books/NBK599526/
pro,NBK587440,"Nursing, Allied Health, and Interprofessional Team Monitoring",https://www.ncbi.nlm.nih.gov/books/NBK587440/
prop,NBK545193,Table. Proposed Diagnostic Criteria,https://www.ncbi.nlm.nih.gov/books/NBK545193/
protein,NBK613290,"Biochemistry, Intermediate Density Lipoprotein",https://www.ncbi.nlm.nih.gov/books/NBK613290/
pu,NBK560880,Table 4. Common Differential Diagnoses of Extrinsic Pulmonary Restriction,https://www.ncbi.nlm.nih.gov/books/NBK560880/
r,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
remdesivir,NBK589640,Safe and Effective Use of Baricitinib and Remdesivir in Hospitalized Patients With Coronavirus (COVID-19),https://www.ncbi.nlm.nih.gov/books/NBK589640/
romiplostim,NBK599500,Table 1. Dosage Adjustments for Romiplostim as per the FDA Label,https://www.ncbi.nlm.nih.gov/books/NBK599500/
ros,NBK619810,Table 1. A Comparison Between Holmium Laser Enucleation of the Prostate and Thulium Laser Enucleation of the Prostate,https://www.ncbi.nlm.nih.gov/books/NBK619810/
rosuvastatin,NBK539883,Table 1. Drug-Drug Interactions and Associated Clinical Recommendations for Rosuvastatin,https://www.ncbi.nlm.nih.gov/books/NBK539883/
sage,NBK482325,Table 3. Dosage of Pancreatic Enzyme Replacement Therapy,https://www.ncbi.nlm.nih.gov/books/NBK482325/
se,NBK430874,"Table 1. Bartonella spp: Main Clinical Syndrome, Vector, and Reservoir",https://www.ncbi.nlm.nih.gov/books/NBK430874/
semaglutide,NBK603723,Semaglutide,https://www.ncbi.nlm.nih.gov/books/NBK603723/
sevelamer,NBK607999,Sevelamer,https://www.ncbi.nlm.nih.gov/books/NBK607999/
sh 0.1%,NBK499965,Table 2. Common Causes of Dyspnea and Their Distinguishing Clinical Features,https://www.ncbi.nlm.nih.gov/books/NBK499965/
sident,NBK610690,Table. Delusional Misidentification Syndromes and Subtypes ,https://www.ncbi.nlm.nih.gov/books/NBK610690/
silica,NBK599506,"Dental Materials: Biodentine, a Calcium Silicate Bioactive",https://www.ncbi.nlm.nih.gov/books/NBK599506/
silico,NBK594245,Silicosis,https://www.ncbi.nlm.nih.gov/books/NBK594245/
sms,NBK570558,Table 1. Etiological Categories and Mechanisms of Duane Retraction Syndrome,https://www.ncbi.nlm.nih.gov/books/NBK570558/
somatostatin,NBK551613,Table 1. Somatostatinoma Associated Syndromes,https://www.ncbi.nlm.nih.gov/books/NBK551613/
standardized,NBK499817,Table 1. Standardized Classification System for Lupus Nephritis,https://www.ncbi.nlm.nih.gov/books/NBK499817/
tadalafil,NBK603743,Tadalafil,https://www.ncbi.nlm.nih.gov/books/NBK603743/
tar,NBK539705,Table 3. Overview of the Plantar Intrinsic Foot Muscles,https://www.ncbi.nlm.nih.gov/books/NBK539705/
tetrazepam,NBK599496,Temazepam,https://www.ncbi.nlm.nih.gov/books/NBK599496/
thy,NBK560583,Table 9. Prognostic Indicators in Compressive Optic Neuropathy,https://www.ncbi.nlm.nih.gov/books/NBK560583/
thyroxine,NBK538485,Table. Dosing in levothyroxine-naïve hypothyroidism individuals diagnosed during pregnancy ,https://www.ncbi.nlm.nih.gov/books/NBK538485/
ticagrelor,NBK594269,Cangrelor,https://www.ncbi.nlm.nih.gov/books/NBK594269/
topiramate,NBK618375,Table 4. Phentermine-Topiramate Clinical Profile,https://www.ncbi.nlm.nih.gov/books/NBK618375/
tretinoin,NBK525949,Table 1. Available Oral Isotretinoin Formulations and Brand Names,https://www.ncbi.nlm.nih.gov/books/NBK525949/
triethylamine,NBK594255,Trimethylaminuria,https://www.ncbi.nlm.nih.gov/books/NBK594255/
type 2,NBK592412,Table 2. Bariatric Surgery Outcomes and Recommendations in Patients With Type 2 Diabetes ,https://www.ncbi.nlm.nih.gov/books/NBK592412/
urea,NBK599513,Nitrosoureas Toxicity,https://www.ncbi.nlm.nih.gov/books/NBK599513/
urea 10%,NBK599513,Nitrosoureas Toxicity,https://www.ncbi.nlm.nih.gov/books/NBK599513/
uva,NBK539883,Table 1. Drug-Drug Interactions and Associated Clinical Recommendations for Rosuvastatin,https://www.ncbi.nlm.nih.gov/books/NBK539883/
v,NBK539871,Review Questions,https://www.ncbi.nlm.nih.gov/books/NBK539871/
ve,NBK560567,Table 2. Endoscopic Third Ventriculostomy Success Score,https://www.ncbi.nlm.nih.gov/books/NBK560567/
vegetable digestive enzyme complex (digezyme),NBK551714,Table,https://www.ncbi.nlm.nih.gov/books/NBK551714/
vegetable glycerin,NBK551714,Table,https://www.ncbi.nlm.nih.gov/books/NBK551714/
vegetable glycerine,NBK551714,Table,https://www.ncbi.nlm.nih.gov/books/NBK551714/
vegetables,NBK551714,Table,https://www.ncbi.nlm.nih.gov/books/NBK551714/
vera,NBK618374,Table 1. Insurance Coverage Strategies for Obesity Treatments,https://www.ncbi.nlm.nih.gov/books/NBK618374/
vit,NBK587448,Continuing Education Activity,https://www.ncbi.nlm.nih.gov/books/NBK587448/
vita,NBK546667,Table 13. B Vitamin Deficiencies,https://www.ncbi.nlm.nih.gov/books/NBK546667/
vitami,NBK546667,Table 13. B Vitamin Deficiencies,https://www.ncbi.nlm.nih.gov/books/NBK546667/
vitamin,NBK546667,Table 13. B Vitamin Deficiencies,https://www.ncbi.nlm.nih.gov/books/NBK546667/
vitamin (a,NBK546667,Table 9. Minimum Daily Vitamin and Mineral Intake After Bariatric Surgery,https://www.ncbi.nlm.nih.gov/books/NBK546667/
vitamin (d,NBK546667,Table 13. B Vitamin Deficiencies,https://www.ncbi.nlm.nih.gov/books/NBK546667/
vitamin 20mg,NBK546667,Table 13. B Vitamin Deficiencies,https://www.ncbi.nlm.nih.gov/books/NBK546667/
vitamin a,NBK546667,Table 9. Minimum Daily Vitamin and Mineral Intake After Bariatric Surgery,https://www.ncbi.nlm.nih.gov/books/NBK546667/
vitamin d,NBK546667,Table 13. B Vitamin Deficiencies,https://www.ncbi.nlm.nih.gov/books/NBK546667/
vitamin d 10000iu,NBK546667,Table 13. B Vitamin Deficiencies,https://www.ncbi.nlm.nih.gov/books/NBK546667/
vitamin d 4000 iu,NBK546667,Table 13. B Vitamin Deficiencies,https://www.ncbi.nlm.nih.gov/books/NBK546667/
vitamin d 400iu,NBK546667,Table 13. B Vitamin Deficiencies,https://www.ncbi.nlm.nih.gov/books/NBK546667/
vitamin e and gold particles. vegetable glycerine,NBK551714,Table,https://www.ncbi.nlm.nih.gov/books/NBK551714/
vitamin(a,NBK546667,Table 9. Minimum Daily Vitamin and Mineral Intake After Bariatric Surgery,https://www.ncbi.nlm.nih.gov/books/NBK546667/
vitis,NBK551572,Table 1. Bacterial Conjunctivitis Organism Features,https://www.ncbi.nlm.nih.gov/books/NBK551572/
water,NBK599552,Water Vapor Thermal Ablation of the Prostate,https://www.ncbi.nlm.nih.gov/books/NBK599552/
water.,NBK599552,Water Vapor Thermal Ablation of the Prostate,https://www.ncbi.nlm.nih.gov/books/NBK599552/
